Friday, May 5, 2023
11:46 AM EST – Oncolytics Biotech Inc. : Announced recent operational highlights and financial results for the first quarter ended March 31, 2023. As of March 31, 2023, the Company reported $29.7 million in cash, cash equivalents, and marketable securities. The net loss for the first quarter of 2023 was $6.4 million, compared to a net loss of $6.8 million for the first quarter of 2022. The basic and diluted loss per share was $0.10 in the first quarter of 2023, compared to a basic and diluted loss per share of $0.12 in the first quarter of 2022. Oncolytics Biotech Inc. (T.ONC ) shares were up $0.10 at 2.08.
Stocks in Play: Oncolytics Biotech Inc., Fri, 05 May 2023 11:57:07 EST